Response of metastatic breast cancer to trastuzumab?

被引:18
|
作者
Barnes, DM [1 ]
Miles, DW
机构
[1] Guys Hosp, Imperial Canc Res Fund, Breast Pathol Lab, London SE1 9RT, England
[2] Guys Hosp, Imperial Canc Res Fund, Breast Biol Grp, London SE1 9RT, England
来源
LANCET | 2000年 / 355卷 / 9199期
关键词
D O I
10.1016/S0140-6736(99)00430-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:160 / 161
页数:2
相关论文
共 50 条
  • [1] Trastuzumab in metastatic breast cancer
    Tomao, F.
    Miele, E.
    Spinelli, G. P.
    Russillo, M.
    La Ferla, G.
    Tomao, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (03) : 247 - 249
  • [2] Subcutaneous trastuzumab in metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (01)
  • [3] Trastuzumab and capecitabine for metastatic breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1039): : 106 - 108
  • [4] Gemcitabine and trastuzumab in metastatic breast cancer
    O'Shaughnessy, J
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 22 - 26
  • [5] Correlation between NK function and response to trastuzumab in metastatic breast cancer
    Beano, A.
    Signorino, E.
    Polimeni, M. A.
    Mistrangelo, M.
    Ardine, M.
    Spadi, R.
    Donadio, M.
    Ciuffreda, L.
    Matera, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Identifying novel molecular markers of response to trastuzumab in metastatic breast cancer
    Jerzak, Katarzyna Joanna
    Desautels, Danielle N.
    Blanchette, Phillip S.
    Bayani, Jane
    Nofech-Mozes, Sharon
    Yaffe, Martin J.
    Pond, Gregory
    Pritchard, Kathleen I.
    Bartlett, John M. S.
    CANCER RESEARCH, 2020, 80 (04)
  • [7] Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
    Beano, Alessandra
    Signorino, Elena
    Evangelista, Andrea
    Brusa, Davide
    Mistrangelo, Marinella
    Polimeni, Maria Antonia
    Spadi, Rosella
    Donadio, Michela
    Ciuffreda, Libero
    Matera, Lina
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [8] Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
    de Alava, Enrique
    Ocana, Alberto
    Abad, Mar
    Carlos Montero, Juan
    Esparis-Ogando, Azucena
    Rodriguez, Cesar A.
    Otero, Ana P.
    Hernandez, Teresa
    Cruz, Juan J.
    Pandiella, Atanasio
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : 2656 - 2663
  • [9] Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
    Alessandra Beano
    Elena Signorino
    Andrea Evangelista
    Davide Brusa
    Marinella Mistrangelo
    Maria Antonia Polimeni
    Rosella Spadi
    Michela Donadio
    Libero Ciuffreda
    Lina Matera
    Journal of Translational Medicine, 6
  • [10] Clinical and molecular predictors of sustained response to trastuzumab in metastatic breast cancer.
    Robinson, A
    Ellard, S
    Speers, C
    Turbin, D
    Yorida, E
    Rajput, A
    Thomson, T
    Huntsman, D
    Gelmon, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 4S - 4S